65,437 trials
Diabetes · Diabetes Mellitus, Type 2
Primary: Change From Baseline in HbA1c (Glycosylated Haemoglobin) Tested for Non-inferiority of IDegLira vs IDeg and Superiority of IDegLira vs Lira — -2.42; -1.80; -1.80…
Healthy Volunteers
Primary: Maximum Observed Plasma Concentration (Cmax) of Lanadelumab — 21.91; 21.42 microgram per milliliter (ug/mL)
Healthy
Primary: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve From Zero to Infinity (AUC[0-∞]) of Dulaglutide — 37400; 40000 nanogram.hour/milliliter (ng.h/mL)…
Dengue · Dengue Hemorrhagic Fever · Yellow Fever
Primary: Percentage of Flavi Virus (FV) Non-immune Participants With Seroconversion Against YF Antigen After Vaccination With Yellow Fever (YF) Vaccine (Stamaril®) Concomitantly…
Dengue · Dengue Fever · Dengue Hemorrhagic Fever
Primary: Event Rate Per 100 Participant-years for Hospitalized Virologically-Confirmed Dengue (VCD) Cases Due to Any and Each Serotype Following Vaccination With Either CYD…
Discharge Follow-up Phone Calls
Primary: Number of Participants With In-patient Re-admissions — 228; 232 Participants — p=.05
Tuberculosis
Primary: Safety Profile of H4:IC31 and BCG Revaccination in HIV-uninfected, Remotely BCG Vaccinated Adolescents. — 286; 1257; 272 number of AEs
Colorectal Cancer Screening
Primary: Colorectal Cancer (CRC) Screening Completion — 99; 99 Participants
Long QT Syndrome
Primary: PK (Pharmacokinetic) Parameter: AUCinf of Eleclazine — 42503.2; 50064.7; 57795.9; 39173.2 h*ng/mL
Neonatal Hypoglycemia
Primary: Sensor-detected Hypoglycemia — 5; 1 events
Choroideremia
Primary: Change in Best Corrected Visual Acuity From Baseline — 3.0 Letters
Ventricular Outflow Tract Tachycardia
Primary: Percent of Ablation Targets With Termination of the Clinical Ventricular Arrhythmia After RF Energy Delivery — 20 Participants
Dengue Fever · Dengue Hemorrhagic Fever
Primary: Percentage of Participants Reporting Solicited Injection-site and Systemic Reactions Following Any and Each Vaccination With Either CYD Dengue Vaccine or a Placebo…
Eating Behaviour
Primary: Egg Intake — 5; 4 eggs
Degenerative Disc Disease
Primary: Radiographic Fusion — 66; 46; 37; 75 percentage of subjects